General Information about Femara
Breast cancer is one of the most common types of cancer in women, with over 2 million cases diagnosed each year worldwide. Hormonally-responsive breast cancer, also known as hormone receptor-positive breast cancer, accounts for about 70% of all cases. This type of cancer is characterized by the presence of hormone receptors in the breast cancer cells, which can be targeted and treated with specific medications. One such medication is Femara, an aromatase inhibitor that is used to treat hormonally-responsive breast cancer.
Femara, also known by its generic name letrozole, belongs to a class of drugs called aromatase inhibitors. These medications work by blocking the production of estrogen in the body, which is known to promote the growth of hormone receptor-positive breast cancer cells. By reducing the levels of estrogen, Femara can slow or stop the growth of these cancer cells, ultimately leading to the shrinkage and regression of the tumor.
Femara is commonly used as a first-line treatment for postmenopausal women with hormone receptor-positive breast cancer, either alone or in combination with other therapies. This medication has also been shown to be effective in treating advanced or metastatic breast cancer, where the cancer has spread to other parts of the body.
One of the advantages of using Femara over other hormone therapy drugs is its reduced risk of developing blood clots and endometrial cancer. This makes it a safer option for women who are at a higher risk for these conditions, such as those with a family history of blood clots or who have previously had breast cancer.
Femara is taken in the form of a daily oral tablet. It works by inhibiting the activity of the enzyme aromatase, which is responsible for converting other hormones into estrogen. By doing so, the drug effectively reduces the production of estrogen in the body, leading to a decrease in the size of the tumor and preventing its growth.
Like any medication, Femara may cause side effects in some individuals. The most common side effects include hot flashes, joint pain, nausea, and fatigue. In some cases, it may also cause bone loss, which can increase the risk of fractures. However, this risk can be reduced by taking calcium and vitamin D supplements.
It is important to consult with a doctor before starting Femara treatment and to discuss any potential risks and benefits. Doctors may also perform regular bone density tests to monitor for any changes and adjust the treatment plan accordingly.
In conclusion, Femara is an effective aromatase inhibitor that has been proven to be beneficial in treating hormonally-responsive breast cancer. With its ability to block estrogen production, it is a valuable tool in the fight against this disease. However, like any medication, it may cause side effects, and regular monitoring by a healthcare professional is necessary to ensure the safety and effectiveness of the treatment. If you or a loved one have been diagnosed with hormone receptor-positive breast cancer, talk to your doctor about whether Femara may be a suitable option for you.
Femara Dosage and Price
Femara 2.5mg
- 30 pills - $76.94
- 60 pills - $117.52
- 90 pills - $158.10
- 120 pills - $198.69
- 180 pills - $279.86
- 270 pills - $401.61